Archive for 2002

FDA rules need tweaking

FDA rules need tweaking The biotech industry is suffering a mini-crisis of confidence that mirrors the larger shocks that have sent Wall Street reeling.


Click here for reuse options!
Copyright 2002 Biotechblog

Cracking the cancer code

Cracking the cancer code Whether a tumor invades the lung or breast is beside the point. Its genetic activity will dictate how to attack it


Click here for reuse options!
Copyright 2002 Biotechblog

Report raps drug firms' 'post-approval' studies

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the Food and Drug Administration primarily so they could make new marketing claims to sell their products, industry specialists said this week. Critics say the trend inflates health care costs while undercutting the integrity of research.


Click here for reuse options!
Copyright 2002 Biotechblog

Report raps drug firms’ ‘post-approval’ studies

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the Food and Drug Administration primarily so they could make new marketing claims to sell their products, industry specialists said this week. Critics say the trend inflates health care costs while undercutting the integrity of research.


Click here for reuse options!
Copyright 2002 Biotechblog

%d bloggers like this: